Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Selective Inhibition of Ribonucleic Acid Synthesis in Staphylococcus aureus by Vancomycin

Abstract

VANCOMYCIN, an antibiotic obtained from Streptomyces orientalis, is effective against a number of growing bacteria, particularly those which are Gram-positive. Mutation to resistance towards this compound is of a very low order, and the antibiotic has been shown to be clinically effective against strains of Staphylococcus aureus which are resistant to the more common antibiotics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gale, E. F., and Folkes, J. P., Biochem. J., 53, 483 (1953).

    Article  CAS  Google Scholar 

  2. Gale, E. F., “Harvey Lectures”, 51, 25 (1957).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

JORDAN, D., INNISS, W. Selective Inhibition of Ribonucleic Acid Synthesis in Staphylococcus aureus by Vancomycin. Nature 184, 1894–1895 (1959). https://doi.org/10.1038/1841894b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1841894b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing